Midday Market Movers: Oil Stocks Surge Amid Venezuela Developments
Major U.S. oil companies saw a significant boost in their shares following the U.S. operation in Venezuela that led to the arrest of leader Nicolás Maduro. Chevron, which already has a presence in the country, rose 5%, while Exxon Mobil advanced 2%. Oilfield services leader Halliburton popped 11% as investors anticipate the rebuilding of energy infrastructure in Venezuela. This development is expected to benefit these companies, given their existing operations and expertise in the region.
Crypto and Tech Stocks See Notable Gains
Coinbase, the crypto exchange, rose 7% after a Goldman Sachs upgrade to buy from neutral. The bank cited the company’s scale and brand recognition as driving factors for its above-average revenue growth and market share gains. Okta, the access management platform company, saw shares pop roughly 6% after announcing a $1 billion share buyback program. Arista Networks also rose more than 2% following a Piper Sandler upgrade to overweight from neutral, with the firm predicting 2026 as the “Year of Refresh” that should benefit hardware vendors like Arista.
Other Notable Movers
Estee Lauder, the cosmetics company, moved nearly 2% higher on the back of an upgrade at Raymond James to strong buy from market perform. The firm also named it one of its top picks for 2026 as the company executes its turnaround. Domino’s Pizza, on the other hand, slipped more than 3% after a downgrade from TD Cowen, with the analyst citing headwinds from softness in the pizza delivery category. Phillips 66, the oil refiner, rose 7% after agreeing to buy assets and related infrastructure from Lindsey Oil Refinery. Mobileye, the maker of autonomous vehicle tech, rose more than 3% after an upgrade to overweight from equal weight at Barclays.
Biotech and Construction Stocks See Significant Moves
QXO, the roofing and construction products distributor, climbed 19% after securing a $1.2 billion preferred equity investment led by private equity giant Apollo. Duolingo, the language education app, climbed 7% after a Bank of America upgrade to buy from neutral, with the bank citing the company’s value proposition as an entertainment product. However, Zenas BioPharma, the Massachusetts biotech, plunged more than 50% after saying it’s currently ineligible for milestone payments with Royalty Pharma Investments under prior agreements tied to its INDIGO trial for immunoglobulin G4-related disease.
Smart Tip for Readers
When monitoring market movements, it’s essential to consider the broader geopolitical and economic context, as well as the specific factors driving individual stock performance, to make informed decisions. For more information on these market developments, visit Here
